STOCK TITAN

Harmony Biosciences: ETF trust reports 5.1% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Harmony Biosciences Holdings, Inc. (HRMY) is the issuer in a Schedule 13G reporting beneficial ownership of its common stock, with a September 30, 2026 event date. American Century ETF Trust reported 2,945,064 shares (5.1%); American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research each reported 3,113,418 shares (5.4%). Each reported sole voting and dispositive power over its stated amount, with zero shared power. The amounts are separate reporting-person disclosures, not a combined total. ACIM said various advisory clients may receive dividends or sale proceeds, and no individual client owned more than 5% of the class.

Beneficial ownership 2,945,064 shares American Century ETF Trust; event date September 30, 2026
Class ownership percentage 5.1% American Century ETF Trust; event date September 30, 2026
Beneficial ownership 3,113,418 shares Each of American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research; event date September 30, 2026
Class ownership percentage 5.4% Each of American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research; event date September 30, 2026
beneficial ownership regulatory
"Ownership of more than 5 Percent on Behalf of Another Person"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
sole voting power regulatory
"Sole Voting Power 2,945,064.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power regulatory
"Sole Dispositive Power 2,945,064.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
investment adviser regulatory
"an investment adviser registered under Section 203"
An investment adviser is a person or firm that professionally manages money and gives recommendations about buying, selling, or holding investments. Like a financial coach or guide, they have a legal duty to act in a client's best financial interest, so their advice, fees and potential conflicts can directly affect returns and risk — making their role important for investors who want informed, accountable help with portfolios.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HRMY shares did the Schedule 13G reporting persons disclose?

For HRMY, American Century ETF Trust reported 2,945,064 shares (5.1%), while American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research each reported 3,113,418 shares (5.4%). These are separate reporting-person amounts, not a combined total.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





413197104

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



American Century ETF Trust
Signature:American Century ETF Trust
Name/Title:/s/ John Pak / Senior Vice President
Date:11/16/2026
American Century Investment Management, Inc.
Signature:American Century Investment Management, Inc.
Name/Title:/s/ John Pak / Senior Vice President
Date:11/16/2026
American Century Companies, Inc.
Signature:American Century Companies, Inc.
Name/Title:/s/ John Pak / Senior Vice President
Date:11/16/2026
Stowers Institute for Medical Research
Signature:Stowers Institute for Medical Research
Name/Title:/s/ Joselyn Verschelden / Authorized Signer
Date:11/16/2026
Exhibit Information

EXHIBIT Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule. Dated this 16th day of November, 2026. AMERICAN CENTURY ETF TRUST AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. ("ACIM") AMERICAN CENTURY COMPANIES, INC. ("ACC") By: __/s/ John Pak___________________ John Pak Senior Vice President, ACETF, ACIM and ACC STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC By: __/s/ Joselyn Verschelden_________ Joselyn Verschelden Authorized Signer

Keep reading